Argan Oil Exerts an Antiatherogenic Effect by Improving Lipids and Susceptibility of LDL to Oxidation in Type 2 Diabetes Patients

Table 2

Baseline anthropometrical and biological characteristics of both study groups.

Characteristics	Argan oil group	Control group
M/W	23/20	22/21
Age (years)	52.09±10.75	52.29±10.51
Diabetes (years)	7.63±4.34	7.71±4.8
Family history (%)	19.56	15.38
SBP (mmHg)	12.00±2.42	12.77±2.43
DBP (mmHg)	7.67±1.28	7.74±1.34
Hypertension (%)	26.08	23.03
Weight (kg)	75.61±13.08	76.03±13.25
BMI (kg/m^2)	29.67±5.00	29.71±4.90
Overweight (%)	26.08	25.64
Obesity (%)	19.57	21.76
Waist circumference (cm)	100.79±15.46	102±14.92
Metabolic syndrome according to IDF definition %	49.34	51.84
TC (mg/dL)	197±35	191±37
TG (mg/dL)	152±55	150±56
HDL-chol (mg/dL)	39±7	34±5
LDL-chol (mg/dL)	127±39	127±33
Apo B (mg/dL)	82.90±20.13	86.83
Apo AI (mg/dL)	106.84±17	106.24±14
Apo B/Apo AI	0.65	0.66
HbA1C %	8.8±1	9±0.7
CRP (mg/dL)	5.22±1.7	5.34±1.4
Creatinine (mg/dL)	6.1±1.16	6.07±1.2
Lag time (min)	52.70	53
MR (mol diene/mol LDL/min)	3.83	3.86
MDP (mol diene/mol LDL)	520.17	521.80

Abbreviations: Apo AI: apolipoprotein AI; Apo B: apolipoprotein B; BMI: body mass index; CRP: C-reactive protein; DBP: diastolic blood pressure; HDL-chol: high density lipoprotein cholesterol; IDF: International Diabetes Federation; LDL-chol: low density lipoprotein cholesterol; M: men; MDP: maximum diene production; MR: maximal rate; TC: total cholesterol; TG: triglycerides; W: women.